Ly-1 inducer T cells play a critical role in the regulation of antibody synthesis. One subset of Ly-1 T inducer cells (Qa-1-) can activate B lymphocytes to secrete IgM (1). A second (Qa-1 +) stimulates Ly-l,2 + T cells to differentiate into Ly-2 + T suppressor cells (1-3) that inactivate both subsets of inducer T cells, resulting in reduced levels of antibody formation and suppression.
and the indicated antigen.
[3H]Thymidine incorporation was assayed on day 2 by pulse labeling cells at 24 h with 1 ~,Ci [3H]thymidine (New England Nuclear, Boston, MA) and culturing for an additional 18 h. Results are expressed as mean counts per minute (cpm) of triplicate cultures.
Preparation of Enriched B or Ly-I Cells
B cells plus accessory cells were purified by adherence of whole spleen cells (3 x 107) to petri dishes (1029; Falcon Labware) coated with goat anti-mouse IgM (11) . Nonadherent cells were removed by several washes in Cantor's balanced salts (Irvine Scientific, Santa Ana, CA) containing 0.1% bovine serum albumin (BSA). The adherent cells were dissociated from the dishes by vigorous pipetting. To eliminate contaminating T cells, the eluted cells were incubated with monoclonal anti-Thy-l.2, anti-Ly-l.2, and anti-Ly-2.2 antibodies, plus rabbit complement, for 45 min at 37°C. To prepare Ly-l-enriched cells, the nonadherent cells from the goat anti-mouse IgM-coated petri dishes were incubated on rat anti-Ly-1-coated petri dishes (12) , eluted, and treated with monoclonal anti-Ly-2.2 and rabbit complement. Populations of both enriched B cells (92% Ig +) and Ly-1 cells (93% Ly-1 ÷) still contained accessory cells.
t~rified B Cells
B cells plus accessory cells (purification described above) were depleted of adherent cells by passage over Sephadex G 10 columns (13) .
Adherent and Antigen-pulsed Adherent Cells
To prepare adherent, antigen-presenting cells, 2.5 x 10 ~ nonimmune whole spleen cells were incubated for 60-90 min in microtiter wells (3040; Falcon Labware) in complete DME medium containing 10% FCS at 37°C. To prepare antigen-pulsed adherent cells, antigen was included during the 60-90 min incubation period. To deplete cultures of nonadherent cells, the microtiter wells were washed by vigorous pipetting with fresh medium at least five times.
Miniature Mishell-Dutton Cultures
Immune spleen cells (106) or B cells (6 X 10 ~) with or without immune Ly-1 T cells (2.5 x 10 ~) were cultured in microtiter wells (3040; Falcon Labware) in complete DME supplemented with 10% FCS, 100 U/ml penicillin, 100 ~,g/ml streptomycin, 0.3% Fungizone (Gibco Laboratories, Grand Island, NY) (14) . A pool of triplicate cultures was assayed for hemolytic plaque-forming cells (PFC) by modification of the Jerne plaque technique (15) , using trinitrophylated sheep red blood cells (TNP-SRBC) (16) or arsanylated SRBC (ARS-SRBC) (17) . In response to DNP-proteins, the PFC assay detects antibody that is crossreactive with TNP. To develop total PFC, rabbit anti-mouse Fc of IgG was added to the complement; IgG PFC were calculated as total PFC minus direct PFC (IgM) (18) . The avidity of the IgM or IgG PFC was determined by hapten inhibition (19) . In response to DNP-KLH or DNP-OVA, IgG anti-DNP PFC were 90-95% inhibited by 10 -~ M DNP-lysine.
Results

Activation of Ly-1 T Cell Clones
Antigen specificity. The response of the OVA-specific clone Ly-l-03 to OVA was detectable at 0.01 #g/ml and maximal at 1 ~g/ml. The clone was also activated by hapten conjugates of OVA such as DNP-OVA, ARS-OVA, or DNP-OVA-ARS, and maximal responses to the latter required 10-fold lower concentrations than to conjugated OVA. Clone Ly-l-03 recognized OVA and not hapten determinants on the conjugates, since DNP-KLH and ARS-KLH did not stimulate responses even at high concentrations ( Fig. 1 A and The ARS-specific clone, Ly-l-Ar-5, responded to ARS-OVA, ARS-KLH, and DNP-OVA-ARS, and did not respond to DNP-KLH and DNP-OVA.
[3H]-Thymidine incorporation was detectable after stimulation by 0.10 ug/ml ARS-KLH and DNP-OVA-ARS or 1.0 ug/ml ARS-OVA; it was maximal at 1.0 ~g/ ml ARS-KLH and DNP-OVA-ARS, and 10 #g/ml ARS-OVA (Fig. 1B) .
Antigen-presenting cells. Clone Ly-l-03 responded to OVA presented by irradiated whole spleen cells, purified B cells, and pulsed or unpulsed splenic adherent cells ( Fig. 2A) (20) . At 1.0 ~g/ml OVA, spleen cells were twice as efficient as either purified B cells or adherent cells in presenting antigen; at higher concentrations of antigen (e.g., 10 /~g/ml), there was no difference between the three cell populations (data not shown). Similarly, we found that all of the above cell types can present arsanylated proteins to clone Ly-l-Ar-5.
Genetic restriction. The response to OVA by clone Ly-l-03 required recognition of I-A s. B10.D2 and B10.GD but not B10.A spleen cells presented OVA to clone Ly-l-03 (Fig. 2B) . The resulting proliferative response was inhibited only by monoclonal anti-I-A s (MK-D6) and not by anti-I-E a [H7-8.26(7A), 14-4-4S] (not shown). Clone 03 also responded to OVA presented by F~ strains like (BALB/cJ × A/J)FI (CAFI) and (B10.A X B10.D2) (Fig. 2B) . Similarly, the CAFl-derived clone Ly-l-Ar-5 responds to arsanylated protein in association with I-A d on antigen-presenting cells from CAFI, parent BALB/cJ, but not A/J (10, 21) .
Both T cell clones produce factors typical of Ly-l + cells. Both T cell clones are Thy-1 +, Ly-1 +, Ly-2-and, after stimulation with antigen-pulsed adherent cells, produce several proliferation and differentiation factors: IL-2, IL-3, and B cell growth factors, BCGF-1 and BCGF-2, (data not shown; and 22, 23 Number of Ceils (x 10 -s) Spleen Cell+ 1.0 pg/ml OVA Therefore, we tested the possibility that these Ly-1 cloned T cells inhibited differentiation of antibody-secreting B cells. Addition of 104 Ly-l-03 cells to DNP-OVA-immune spleen cells incubated with DNP-OVA completely inhibited the secondary IgG anti-DNP PFC response. Inhibition was antigen specific, since Ly-l-03 did not significantly affect the IgG PFC response of DNP-KLH-primed spleen cells in DNP-KLH-stimulated cultures (Table I) . Similarly, the ARSspecific clone Ar-5 inhibited secondary IgG anti-ARS PFC response in ARS- (Table I) .
Ly-1 T Cell Clones Specifically Inhibit Ig Secretion of B Cells
Conditions for inhibition.
To determine the number of inducer cells required for inhibition, increasing numbers of Ly-l-03 (10 to 104 cells) were added to cultures stimulated with 0.01 ~g/ml DNP-OVA. Significant inhibition was seen with as few as 10-100 Ly-l-03 cells; maximal inhibition (95-100%) occurred when 5 X 103 to 104 cells were added. Irradiation of the T cell clone slightly decreased its ability to inhibit the PFC response to DNP-OVA (Fig. 3A) .
DNP-OVA-immune spleen cell cultures were stimulated in vitro with increasing concentrations of DNP-OVA, from 0.001 to 10 ug/ml. The addition of 104 irradiated (Fig. 3B ) or nonirradiated (data not shown) clone Ly-l-03 cells caused 75-100% inhibition of the IgG anti-DNP response at all concentrations tested. Inhibition was maximal (92%) at 0.001 eg/ml DNP-OVA, 100-fold less than that required to induce optimal DNA synthesis (Figs. 3B and 1A).
Cellular Mechanisms of Inhibition
Ly-2 T suppressors are not required for inhibition. Previous analysis (1-3) of Ly-1 induction of suppression showed that these cells activate Ly-2 T suppressors in vitro which, in turn, inactivate Ly-1 T helper activity. We therefore tested whether inhibition by clones 03 and Ar-5 required antigen-specific Ly-2 T suppressors.
B cells from DNP-immune donors were incubated with OVA-specific Ly-1 Th cells, and DNP-OVA or DNP-OVA-ARS. When Ly-l-03 was added to these cultures, the IgG PFC response was completely inhibited ( dependent and MHC-restricted IgG PFC response to DNP-KLH in BALB/c and CAF~ mice. The IgG response was MHC restricted rather than dependent on nonspecific factors. The PFC response was inhibited by anti-class II (I-A, I-E) antibodies, and supernatants from Con A-stimulated cells did not induce significant IgG secretion by purified DNP-KLH-immune B cells (29) . To test whether inhibition was effective when the Ly-1 clone was focused onto B cells, we compared the ability of Ly-l-03 to inhibit DNP-KLH responses in the presence of DNP-OVA and OVA. These two antigens were almost equivalent in their ability to activate the clone (Fig. 1A) , but only DNP-OVA was capable of also binding to DNP-specific B cells from DNP-KLH-immune mice. DNP-KLH-immune spleen cells were stimulated with increasing concentrations of OVA or DNP-OVA (0.001-10 #g/mi) in the presence or absence of 10 4 Ly-1-03 T cells. The IgG anti-DNP response was 75% inhibited in cultures containing 0.001 •g/ml DNP-OVA plus 104 Ly-1-03, and completely inhibited by 0.01-0.1 #g/ml DNP-OVA plus 10 4 Ly-l-03. In contrast, inhibition in cultures containing OVA was significant (86%) only at 1 t~g/ml (Fig. 5A) . Thus, although DNP-OVA was only 10-fold more efficient than OVA in activation of Ly-l-03 (0.1 vs. 1.0 ~g/ml, respectively; Fig. 1A ), DNP-OVA was 1,000-fold more efficient than OVA in inhibiting IgG anti-DNP responses (Fig. 5A) .
This result suggests that inhibition by clone Ly-l-03, like help mediated by Ly-1 T cells, is most effective if the clone makes contact with B cells through an antigen bridge. Again, as in Th and B cell interactions, the antigen bridge can be mediated by antigen-pulsed adherent cells (31) . Spleen cells (depleted of adherent cells) from DNP-KLH-immune BALB/c mice were added to cultures containing adherent cells from nonimmune BALB/c mice pulsed with increasing concentrations of DNP-OVA. The cultures that contained adherent cells pulsed with 0.10 gg/ml DNP-OVA and 104 Ly-l-03 were 99% inhibited. The inhibition was equivalent to cultures that had soluble DNP-OVA and Ly-l-03 added in the beginning of the culture period (Fig. 5B ).
Ly-I T cell clone and Ly-I Th interaction.
In addition to the direct inactivation of B ceils described above, it was also possible that the Ly-1 T cell clones could interact with and functionally inactivate the Ly-1 Th cells required for B cell maturation (32) . This possibility was directly tested: Ly-l-Ar-5 cells were added to cultures containing DNP-KLH-immune spleen cells, and were stimulated with DNP-KLH as well as either DNP-OVA-ARS, to focus the clone onto B cells (controls DNP-OVA and ARS-OVA), or ARS-KLH (control ARS-OVA), to focus the clone onto carrier-specific Th cells.
Clone Ly-l-Ar-5 behaved similarly to clone Ly-l-03, in that B cell-directed antigens were more effective at inhibiting a DNP-KLH response. DNP-OVA-ARS elicited 50% inhibition at 0.001 #g/ml and 95% inhibition at 0.01-0.10 #g/ml, in cultures containing 10 4 Ly-l-Ar-5 (Fig. 6A) . The non-B-cell-directed antigen control, ARS-OVA, was 1,000-fold less effective, since it elicited only 50% inhibition at 1 ug/ml (Fig. 6B) .
To focus Ly-l-Ar-5 T cells onto KLH-specific Ly-1 Th cells, increasing concentrations of ARS-KLH were added to anti-Ly-2.2-treated DNP-KLHimmune spleen cells. If one component of inhibition requires an antigen-specific interaction between the Ly-1 T cell clone Ar-5 and KLH-specific Th cells, then ARS-KLH should be comparatively more efficient at eliciting inhibition than ARS-OVA. However, we detected no difference between ARS-KLH and ARS-OVA, even though cultures contained KLH-specific Th cells. PFC responses in cultures containing ARS-KLH and ARS-OVA were ~educed 50% at 1 gg/ml, in the presence of 104 clone Ly-l-Ar-5 cells (Fig. 6B ). In the same experiment, the antigen DNP-OVA-ARS, which focuses the clone onto DNP-specific B cells, was 1000-fold more efficient than either ARS-KLH or ARS-OVA, as described above (Fig. 6B) . The more potent inhibition by DNP-OVA-ARS vs. ARS-KLH or ARS-OVA cannot be explained by differential activation of the clone, since dose response curves for all the antigens are very similar (Fig. 1 B) . We conclude that Ly-l-Ar-5, like clone Ly-l-03, may inhibit by directly inactivating B cells, and that inactivation of KLH-specific Th cells by clone Ly-l-Ar-5 is unlikely to be the predominant mechanism of inhibition. (Table II) . Similarly, we have shown that the inhibition of B cell secretion by the hapten-specific T cell clone Ar-5 is I-A d restricted (data not shown).
Antigen-specific Interaction Between the Cloned T Cells and B Cells Is I-A d Restricted
It is noteworthy that recognition of one parental MHC molecule (I-A d) by both the BALB/c-derived clone Ly-l-03 and the CAF~-derived clone Ar-5 was sufficient to inhibit the entire response of CAF1 mice, provided that the appropriate B cell-directed antigens (DNP-OVA or DNP-OVA-ARS for clone 03, DNP-OVA-ARS for clone Ar-5) were also present in the cultures (data not shown and Fig. 6A ). We have determined by inhibition with specific anti-Ia antibodies that the DNP-KLH-immune spleen cells from CAF1 mice contain similar levels of helper activity for B cells bearing any of the four I region-coded molecules: I-A k, I-E k, I-A a, and I-E d (data not shown).
Unlike the T-T interaction that generates suppression (3), interaction between the cloned T cells and B cells is not Ig-H restricted; the addition of either T cell clone inhibited IgG anti-DNP PFC in both BALB/c allotype-congenic strains, C.AL/20 (Ig-V) and C.B20 (Ig-I b) (data not shown).
Kinetics of Inhibition
To test if the clone inhibits the early phase of the PFC response, Ly-l-03 was added at time zero with DNP-OVA to DNP-KLH-primed immune spleen cells In experiments and the cultures were assayed for IgM and IgG anti-DNP PFC daily from day 3 to day 6. IgM antibody synthesis was detected from day 3 to 5, and was 60-75% inhibited in the presence of both DNP-OVA and clone Ly-l-03, (Fig. 7A ).
Significant number of IgG PFC were detected beginning on day 4; complete inhibition (95-100%) was seen in the presence of both DNP-OVA and clone Ly-1-03 on all days tested (days 3 to 6, Fig. 7B ). We also tested whether the time of addition of the clone was important for inhibition. We added 104 irradiated Ly-l-03 at 0, 24, 48, and 72 h to separate cultures of immune spleen cells stimulated with DNP-KLH or DNP-OVA. When the clone was added at time 0, IgG PFC responses of DNP-OVA-but not DNP-KLH-stimulated spleen cells were completely inhibited, as tested at days 4-6. The clone inhibited 95% of PFC response when added 24 h after initiation of culture, but did not inhibit when added at later times (Fig. 8) . These data indicate that the Ly-I-B interaction that results in B cell inactivation must occur early (within the first 24 h) of the response.
Short-term Incubation of B Cells with Clone Ly-l-03 Impairs their Ability to Differentiate Into IgG-secreting Plasma Cells
To test whether the clones inactivated B cells before differentiation into IgGsecreting plasma cells, purified B cells from DNP-KLH-immunized mice were incubated with antigens and Ly-l-03 as indicated in Table III . At 48 h, Th cells and cloned Ly-l-03 T cells were eliminated with anti-Thy-l.2, -Ly-l.2, -Ly-2.2, and rabbit complement. After extensive washing, the B cells were cultured with KLH-specific Ly-1 Th cells and DNP-KLH for an additional 5 d, before assaying for an anti-DNP PFC response. Purified B cells that were preincubated with DNP-OVA and Ly-l-03 were irreversibly inhibited from secreting DNP-specific Ig. The inhibition of secretion by DNP-OVA and Ly-l-03 is antigen specific and dose dependent; maximum inhibition (89-95%) occurred when B cells were cultured with 0.01-0.10 •g/ml DNP-OVA (Table III) . Inactivation was not caused by cell lysis; on the contrary, Ly-l-03 delivered an early proliferative signal to the antigen-specific B memory cells. Hapten-purified or DNP-binding B cells were activated by Ly-l-03 T cells in the presence of the same low doses of DNP-OVA (data not shown). 
Co-recognition of an MHC (I-E) and a Non-MHC Molecule on B Cells by Ly-1-03 Inhibits Secretion of Anti-DNP Ig
The Ly-l-03 T cell clone was also activated by I-E d and a non-MHC-encoded antigen (X) present on DBA/2 B cells but not on (BALB/cByJ × DBA/2)F~ B cells (Friedman, S., D, Sillcocks, and H. Cantor, manuscript in preparation). The non-MHC-encoded molecule is a B cell-specific surface antigen not found on adherent cells (Fig. 9A) . Parenthetically, stimulation by I-E and the B cell membrane determinant was less sensitive to irradiation than B cell presentation of soluble antigen. (Figs. 9A and 2A; 2,500 vs. 1,000 rad). The recognition of I-E d + X on DBA/2 B cells resulted in proliferation (Fig. 9A) and production of factors that induce proliferation of DBA/2 B cells (Fig. 9B) , but did not induce polyclonal Ig secretion (data not shown). As few as 103 Ly-l-03 inhibited IgG anti-DNP secretion by DBA/2 B cells to DNP-KLH (Fig. 9C) , and 104 cells completely suppressed the response. The efficiency of suppression was unchanged despite the absence of an antigen bridge to focus Ly-l-03 cells onto the correct (DNP specific) B memory cell. Finally, (BALB/c × DBA/2)F~ B cells, which do not express X and therefore do not activate Ly-1-03, were not inhibited to secrete IgG in the presence of Ly-l-03.
Discussion
Inhibition by Ly-1 T Cell Clones. These data provide the first direct evidence that at least some clones of inducer cells directly inhibit antibody secretion by B memory cells. The inhibitory function of these Ly-1 T cell clones has been stable (Table III) . Inhibition of IgG synthesis or secretion does not require that the Ly-I T cell clones interact via antigen with antigen-specific Ig on the surface of B cells: Ly-l-03 inhibited allogeneic DBA/2 B cells from responding to DNP-KLH by interacting with non-Ig B cell surface molecules (Fig. 9 C) . Inhibition of the secondary antibody responses in vitro does not require induction of T suppressors. Removal of Ly-2 + cells from the cultures by antibody and complement had no effect on inhibition (Fig. 4) . Inhibition was not influenced by Ig-H-linked genes (data not shown), unlike the induction of Ly-2 + suppressors (3, 33) .
Inhibition was seen at concentrations of antigen that do not induce proliferation of the T cell clone (compare Fig. 1 with 5 6A and data not shown). Moreover, we failed to detect inhibition between cloned T cells and Ly-1 Th cells in vitro, even when we attempted to link these two cells by an antigen bridge (Fig. 6B) . These data strongly suggest that the target cell is the B cell rather than Ly-1 Th cells and that the inhibition is not mediated by interference with the positive interaction between B cells and Th cells. Perhaps the DNP-KLH-activated B cells bind more avidly to Ly-1 T cell clones because they express higher concentrations of (I-E d + X) on their surface (35) .
Lack of Helper
The Ly-1 T cell clone may be brought into close contact with the B cells on the surface of antigen-presenting adherent cells (Fig. 5B) (20, 36) , or via released vesicles and/or protein complexes containing Ia and antigen (37, 38) . We favor direct interaction with B cells since recognition of I-E and a non-MHC surface component on B cells was sufficient for inhibition of the response (Fig. 9, A and  C) . Inhibition by the Ly-1 T cell clones is not restricted to the Lyb-5 + B cell subset (39) ; the responses in both (BALB/c X CBA/N)Fl normal (Lyb-5 + and Lyb-5-) and (CBA/N × BALB/c)F1 X-linked immune-deficient (xid) mice were equally inhibited (data not shown).
Both T cell clones inhibit IgG antibody responses to a greater extent than IgM responses. In >50 experiments, IgG-specific responses were inhibited by 80-100%, whereas IgM-specific responses were either inhibited, unaffected, or even enhanced. We feel that the data are best explained by the affinity differences between the two classes of antibody (IgG, Kay = 10 -7 M; IgM, Kay > 10 -5 M) rather than by invoking isotype-restricted suppression (40) . Thus, higher affinity IgG antibodies would be more efficient in forming a B ceil-Ly-1 cell bridge required for inhibition. It is also unlikely that the Ly-1 T cell clones caused the B cells to switcb to a class of Ig not measured in the PFC assays (e.g., IgA); memory B cells committed to IgG synthesis apparently do not switch to another class of Ig (41, 42) .
This inducer-B cell interaction occurs early in the immune response, before differentiation of B cells into Ig-secreting cells. First, as soon as IgG secretion was detected in control cultures, on days 3 or 4, IgG secretion was inhibited in cultures containing antigen-activated Ly-1 T cell clones (Fig. 7) . Second, incubation of DNP-immune B cells with antigen and the Ly-1 T cell clone for 24-48 h prevented these B cells from receiving Th cell signals over the next 5 d (Fig.  8 , Table III) .
Mechanism of B Cell Suppression. T cell clones did not lyse or inhibit proliferation of antigen-specific B cells during the early phase of the response. Nor do these Ly-1 T cell clones lyse B cells, LPS blasts, or Ia-bearing tumor cells, when incubated with antigen ( Fig. 9B and data not shown) . A critical observation is that incubation of B cells with either clone resulted in antigen-dependent proliferation of antigen-specific B memory cells. Affinity-purified, DNP-specific B cells from DNP-KLH-immune spleen cells underwent a substantial proliferative response 24-48 h after incubation with Ly-l-03 in the presence of low concentrations of DNP-OVA; after stimulation with low doses of antigen, the clone does not produce nonspecific B cell proliferative responses (data not shown). Thus, Ly-l-03 induces an early proliferative response of DNP-specific B cells, but inhibits subsequent antibody secretion.
The negative signal imparted by the Ly-1 T cell clones in the presence of soluble antigens is unusual in that it inactivates adult B cells to conventional antigens like DNP3OVA or ARSaOVA. Tolerance of B cells usually requires contact with antigens that present a polyvalent matrix to B cells like DNP-SIII (pneumococcal polysaccharide) or unusual antigens like haptenated Ig vs. haptenated BSA (43) (44) (45) . The gamma globulins are unique tolerogens in that they can impart negative signals to B cells via Fc receptor binding (46) . We have used a conventional antigen (e.g., DNP3OVA) at concentrations (_10 -9 M) that are 100-1,000-fold less than usually required to inhibit adult B cells by equivalently haptenated Ig (45) . The inactivating molecule is not the antigen-binding T cell receptor secreted by Ly-1 T cell clones. On the contrary, whereas antigenbinding material secreted by a TNP-specific Ly-1 T cell clone provides positive signals for B cell maturation and IgM secretion (47, 48) , the same T cell clone inhibits the secretion of IgG when it makes an antigen-specific and I regionrestricted contact with B cells (data not shown). If receptor blockade is the mechanism of inactivation by the clones, then the molecules causing the blockade are bound so tightly to the Ig receptor that they can not be removed by extensive washing (Table III) . If, instead, the T cell clones cause receptor modulation of B cells, then the T cell must present the antigen bound to its receptor in a bivalent or multivalent complex that leads to patching, capping, and endocytosis of membrane Ig receptor (43) .
It is possible that the Ly-1 T cell clone releases factors (49) (other than antigenbinding factors) that impart a negative signal only to the B cell with which it has previously made the antigen-specific and MHC-restricted contact. Whatever the negative signal may be, it cannot be neutralized by LPS, a polyclonal activator of B cells (data not shown; 50).
Relevance to the In Vivo Immune Response. These T cell clones can also inhibit secondary antibody responses in vivo. Secondary IgG anti-DNP responses of mice immunized with DNP-KLH were inhibited by simultaneous injection of clone Ly-l-03 and DNP-OVA, or to a lesser extent with OVA (Friedman, S., D. Sillcocks, and H. Cantor, manuscript in preparation). Ly-1 T cells with similar function to Ly-l-03 may regulate physiological antibody responses to DNP-OVA by one of two mechanisms. As the immune response progresses, more B cells with higher affinity antibody will be selected and thus more of these B cells may be inactivated by antigen-specific suppressor Ly-1 T cells. Alternatively, these Ly-1 T cells may expand a population of antigen-specific B cells to become memory B cells that are refractory to secretion until the next antigenic challenge.
Analysis of inducer T cell clones thus indicates that the set of Ly-1/OKT4 + T cells may include cells that differentially regulate B cell activation and maturation (51, 52) . Further studies should help to clarify the role of each in the production of appropriate immune responses to foreign and autoiogous proteins. 
